edoc

Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting

Matter-Walstra, Klazien Wietske and Schwenkglenks, Matthia and Dedes, Konstantin J.. (2017) Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting. Breast cancer research and treatment, 163 (3). p. 635.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/74324/

Downloads: Statistics Overview


Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:Schwenkglenks, Matthias and Matter-Walstra, Klazien Wietske
Item Type:Article, refereed
Article Subtype:Further Journal Contribution
ISSN:1573-7217
Note:Publication type according to Uni Basel Research Database: Journal item
Identification Number:
Last Modified:30 Mar 2020 17:40
Deposited On:30 Mar 2020 17:40

Repository Staff Only: item control page